Clinical Trial Detail

NCT ID NCT02513563
Title AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

lung squamous cell carcinoma

Therapies

Carboplatin + Paclitaxel

Adavosertib

Age Groups: adult

No variant requirements are available.